Amgen is committed to clear and ongoing communications with the patients, physicians and people we serve. We recognize that strong relationships are critical to our ability to best serve patients, and that our relationships are built upon ethical and responsible business conduct and reliable disclosure of information. In this section you can learn about the policies and principles that govern Amgen's business practices.
Clinical Trials Information and Results
Amgentrials.com offers patients, investigators and the public easily accessible information about Amgen-sponsored clinical trials, including enrollment information for actively recruiting studies and results summaries for completed ones (consistent with the company’s clinical results disclosure policy - see below)
Clinical Trials and Results Disclosure Policy
Amgen is committed to the timely communication of scientifically valid results, both positive and negative, from our clinical trials.
Global Code of Ethics for Clinical Trials
Amgen is committed to protecting the rights of clinical trial participants worldwide.
Scientific Exchange
Amgen is committed to truthful, non-misleading exchange of medical and scientific information, including clear and objective communications of risks, benefits, and safety.
Policy on the Support of U.S. Clinical Practice and Treatment Guidelines
Amgen occasionally offers financial support to independent bodies who develop clinical and treatment guidelines. Amgen does not exert any influence or control over the development of guidelines that it has funded.
Adverse Event Reporting
An “Adverse Event” is any new, undesirable medical experience or change in an existing condition which occurs during or after use of any marketed or investigational product. Amgen staff are required to report Adverse Events within one business day.
R&D Activities with External Parties
All Amgen sponsored, funded, or otherwise supported research activities with external parties are designed to fill a legitimate research need and it is prohibited to influence or encourage purchase, prescription, placement or sale of Amgen products.
R&D Gifts Policy
Amgen staff and their representatives in Global Research and Development organization are not permitted to provide gifts of any nature to healthcare professional and/or members of the scientific community.
Commitment to the Ethical Use of Animals in Research
Most regulating bodies, including the FDA, require that potential medicines be thoroughly tested in animals prior to human testing. In our research, Amgen seeks to eliminate or reduce impact to animals, to provide high quality care to laboratory animals, and to use alternatives to animal research whenever possible.
Amgen Guidelines for Publications
Amgen is committed to the highest scientific and ethical standards for publications and is dedicated to providing scientifically accurate, fair, and well-balanced publications to the scientific community.
Amgen Statement on Compendia
Amgen periodically monitors the information contained in CMS-Recognized Compendia and submits corrections or updates as necessary.
Direct-to-Consumer (DTC) Advertising
Amgen is committed to ensuring that any advertising for our products provides accurate, accessible, and useful information to patients and consumers, including balanced presentation of risks and benefits. We follow voluntary industry guidelines governing the responsible use of DTC advertising.
Interactions with Healthcare Professionals and Other Customers
Amgen requires that all interactions with healthcare professionals and other customers comply with all applicable laws and adhere to the highest standards of professional ethics and responsibility. We meet or exceed industry guidelines that place strict limits on meals and other items provided to medical or health professionals.
Promotional Materials and Activities
All of Amgen's U.S. promotional materials are reviewed for rigorous consistency with FDA-approved product labeling. Our marketing practices are based on valid scientific evidence.
Amgen Foundation Grant Guidelines
The Amgen Foundation considers grant requests from regional, national and European nonprofit organizations that work to advance science education, improve quality of care and access for patients, and create sound communities where Amgen staff members live and work.
Amgen Foundation Grant Recipient List
Amgen Medical Education Donations Guidelines
The Amgen Medical Education Department makes donations to qualified organizations that advance medicine and healthcare, promote healthcare professional education, educate the public on diseases and medical conditions, or support other philanthropic and charitable causes that ultimately benefit patients.
Amgen Mission and Values
Amgen aspires to be the best human therapeutics company, using science and innovation to dramatically improve people’s lives. Our mission is to serve patients. Our values define us and form the foundation for our behavior.
Code of Conduct
All staff members are required to complete Amgen’s mandatory course on ethical business conduct and compliance. Amgen expects every staff member and contractor to conduct business ethically, to comply with all applicable laws, and to exert due diligence in preventing and detecting violations of laws or policies.
Quality
Amgen adheres to sound scientific and quality principles and ensures that these principles are reflected in our operations, including research, development, manufacturing and distribution.
Protection of Personal Information Policy
Amgen is committed to the lawful stewardship of personal information that is collected, stored and used by the company.
Insider Trading
Amgen’s policy against insider trading applies to staff members, consultants, contract workers and temporary staff, as well as to members of their families and households.
Conflicts of Interest
Amgen staff are responsible for avoiding situations in which personal interests, outside activities, financial interests or relationships conflict or even appear to conflict with the company’s interests.
Antitrust and Unfair Competition
Amgen does not tolerate any business transaction or activity that violates the antitrust and competition laws of any country in which the company conducts business.
Dealing with the Government
Amgen has a strict policy against any attempt to unlawfully influence government officials.
Board of Directors' Corporate Governance Principles
Amgen’s system of corporate governance emphasizes the Board’s independence and strengthens its ability to evaluate corporate and management performance.
Governance Documents
Amgen has numerous policies and guidelines intended to ensure ethical and conscientious governance.
Environmental Commitment Statement
Amgen is committed to excellence in environmental, health and safety performance.
Environmental Compliance
Amgen is committed to ensuring compliance with environmental regulations. Audits are performed at all Amgen sites including manufacturing, research and development, and distribution facilities.
Professional Conduct
Ethical business conduct, professional behavior, adherence to acceptable business principles, personal integrity and compliance with applicable laws and regulations are expected to be consistently demonstrated at Amgen.
Safe and Healthy Workplace
Safety is a priority at all Amgen locations worldwide. Staff members are expected to participate in safety training, follow safety standards and promptly report any safety concerns.
Diversity
Amgen’s commitment to diversity is articulated in our core values and reflected in every part of our organization.
Environment, Health and Safety
Amgen is committed to achieving high standards of environmental quality and to providing a safe and healthy workplace for all of its staff members, contractors, and temporary staff.
Equal Employment Opportunity
Amgen has policies and programs designed to provide a work environment that is free from unlawful discrimination.
Non-Discrimination & Harassment-Free Work Workplace
Amgen does not tolerate unlawful harassment by or toward employees, or non-employees with whom Amgen has a business, service or professional relationship.
R&D and Manufacturing in a Regulated Environment
It is Amgen’s policy to comply with all applicable laws and regulations regarding its research, development and manufacturing activities, including Good Operating Practices.
Compliance Reporting and Non-Retaliation Policy
Amgen provides an effective process for Amgen staff to express concerns and report potential violations regarding Amgen business conduct without retaliation or intimidation.
Political Activities
While Amgen encourages staff to participate in the political process, personal contributions should not be made with or reimbursed by company funds in U.S. federal campaigns or in other campaigns where it is illegal to do so.
Political Contributions
Amgen’s participation in the political process supports candidates and organizations who work to advance health care innovation and improve patient access. We disclose all our political contributions.
Economic Sanctions, Embargoes and Boycotts
It is Amgen’s policy to comply with applicable sanctions and embargoes imposed by countries in which Amgen operates.
Export Control Laws
Amgen complies with all U.S. export control laws which may restrict the export of goods, software, and technology from the United States.
Foreign Corrupt Practices
Amgen maintains a strict policy against paying, offering to pay, or authorizing the payment of anything of value to any foreign (i.e. non-U.S.) government official, government staff member, political party or political candidate in an attempt to influence a person working in an official capacity.
Pricing
Accurate and timely pricing information about Amgen’s products can assist healthcare providers, government and private payers, patients, and other stakeholders. The calculation, reporting and disclosure of pricing information are also important to Amgen’s commercial success as well as a part of our legal and regulatory obligations.
